Bundibugyo Ebola: Vaccines and Treatments in Development

Public health authorities are currently scrambling to secure medical countermeasures for an outbreak of the Bundibugyo strain of the Ebola virus in the Democratic Republic of Congo. With 2,473 confirmed cases and 999 deaths reported by the government, the lack of approved vaccines or treatments for this specific strain—which carries a fatality rate of up … Read more

Rising Vaccination Rates Combat Global Childhood Outbreaks Amid Conflict

Global childhood vaccination rates rose slightly in 2025, with 90% of infants receiving at least one dose of the DTP vaccine, according to data from the World Health Organization (WHO) and UNICEF. Despite this, 13.5 million children remain “zero-dose,” leaving millions vulnerable to preventable diseases amid funding cuts and active conflicts. The Gap Between First … Read more

FDA Proposes Simplified Registration for Distributed Drug Manufacturers

The U.S. Food and Drug Administration (FDA) has proposed a new regulatory framework designed to modernize how distributed pharmaceutical manufacturing sites register with the agency. Under the proposal, companies utilizing a “hub-and-spoke” manufacturing model—where a central location oversees multiple production units—would be permitted to register as a single establishment. The rule also mandates tighter reporting … Read more

UK May Intervene in $110 Billion Paramount-Warner Bros. Merger

The British government has signaled a potential intervention in the $110 billion merger between Paramount Skydance Corp and Warner Bros. Discovery, citing concerns over media plurality and the regulation of on-demand streaming services. According to a statement from the UK government, Culture Minister Lisa Nandy has set a July 6 deadline for the companies to … Read more

FDA to Review Sandoz Generic GLP-1s

The U.S. Food and Drug Administration (FDA) has officially accepted for review Sandoz’s applications for two generic versions of tirzepatide, the active ingredient in Eli Lilly’s popular weight-loss and diabetes treatments. This regulatory step marks a significant move toward potential market competition for Mounjaro and Zepbound ahead of the expiration of Eli Lilly’s U.S. patents … Read more

China Strips Top Officials and Generals of Lawmaker Status

China’s National People’s Congress (NPC) Standing Committee stripped six military officials and senior regulators of their legislative status on Friday, according to a report from the state-run Xinhua news agency. The dismissals, which lacked official explanation, involve high-ranking figures from the Equipment Development Department and various regional military commands, marking a significant intensification of President … Read more

Trump Threatens 100% Tariffs on Digital Services Tax Nations

U.S. President Donald Trump threatened on Friday to impose a 100% tariff on goods from any country that implements a digital services tax targeting American companies. The warning comes just one day after European Union nations met a July 4 deadline to reduce tariffs on U.S. goods, a move intended to meet commitments under a … Read more

US Deploys Ebola Treatments to Congo for Clinical Trials

The U.S. government has begun shipping stockpiled doses of an experimental antibody drug, MBP134, from Mapp Biopharmaceutical to the Democratic Republic of Congo to combat a widening Bundibugyo Ebola outbreak. According to the U.S. Department of Health and Human Services, this shift in policy marks the first time Washington has released the treatment for clinical … Read more

UK Regulator Suspends ICC Prosecutor Karim Khan

International Criminal Court (ICC) Chief Prosecutor Karim Khan has been suspended by Britain’s Bar Standards Board following allegations of sexual misconduct. This action compounds an existing suspension imposed by the ICC’s governing body on June 8, 2025, leaving the leadership of the world’s permanent war crimes court in flux as it faces significant geopolitical pressure. … Read more

Amazon Raised Concerns Over Anthropic AI Models Before US Regulatory Scrutiny

Anthropic has disabled its advanced AI models, Fable 5 and Mythos 5, on a global scale following U.S. national security orders. The Trump administration mandated the shutdown after officials identified a “jailbreak” vulnerability that could allow users to leverage the technology for identifying cybersecurity flaws. While Anthropic maintains the risks are minor, the move marks … Read more